MAY 18, 2016 10:36 AM PDT

Arctic Sponge Extract May Be Potent Against MRSA

WRITTEN BY: Xuan Pham
Turning back to nature’s marine medicine cabinet, scientists at the University of South Florida (USF) may have found a new chemical that can beat the formidable methicillin-resistant Staphylococcus aureus (MRSA) bacteria. The compound, named “darwinolide,” was extracted from the arctic sea sponge Dendrilla membranosa. The team hopes the new compound will give doctors the upper hand in hospital settings plagued by MRSA infections.
 
New compound in arctic sponge can kill MRSA
The Staphylococcus aureus bacteria are found on the skin and nose of most people – even healthy persons. Most of the time, Staph infections are minor and don’t warrant extensive treatments. However, Staph infections take a serious turn when the bacteria invade the bloodstream and major organs. Even more dangerous, some types of Staph, such as MRSA, have become resistant to antibiotics that are common in a doctor’s arsenal. As such, MRSA infections represent some of the biggest health risks for patients and their doctors.
 
"In recent years, MRSA has become resistant to vancomycin and threatens to take away our most valuable treatment option against staph infections," said Lindsey N. Shaw, USF microbiologist and study co-author.
 
Whereas highly-resistant MRSA used to be mostly confined to the health care settings, such as in hospitals, nursing homes, and dialysis centers – the resistant strain can now be found in high-traffic community areas too. Locker rooms, gyms, and schools also provide good breeding grounds for the MRSA and its spread through the community.
 

One of bacteria’s most effective defenses against antibiotics is its ability to form a biofilm, which are aggregated colonies that secrete a slimy substance that protects the bacteria against the environment. "Biofilms, formed by many pathogenic bacteria during infection, are a collection of cells coated in a variety of carbohydrates, proteins and DNA," said Shaw. "Up to 80 percent of all infections are caused by biofilms and are resistant to therapy. We desperately need new anti-biofilm agents to treat drug resistant bacterial infections like MRSA."
 
Indeed, by going to the ends of the Earth, they may have found an answer in the arctic sea sponge. The team’s leader, Bill Baker, has extensive experience with marine medicine, as he studies the chemical ecology of Antarctica to find natural compounds with pharmaceutical potential.
 
From freeze-dried Antarctic sponges, the team extracted and purified a chemical that they named darwinolide. The compound proved to be effective against the biofilm phase of MRSA, making it a promising compound against this difficult-to-treat infection.
 
"When we screened darwinolide against MRSA we found that only 1.6 percent of the bacterium survived and grew. This suggests that darwinolide may be a good foundation for an urgently needed antibiotic effective against biofilms," said Baker.
 
Despite growing advances in medicine and pharmaceuticals, MRSA account for over 80,000 hospital-acquired infections, leading to over 11,000 deaths every year. "We suggest that darwinolide may present a highly suitable scaffold for the development of urgently needed, novel, anti-biofilm-specific antibiotics," the authors concluded.

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 03, 2020
Genetics & Genomics
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
NOV 03, 2020
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr ...
NOV 05, 2020
Clinical & Molecular DX
Painless Microneedle Patch Diagnoses Malaria in Minutes
NOV 05, 2020
Painless Microneedle Patch Diagnoses Malaria in Minutes
It looks like a Band-Aid — a small, adhesive patch that is applied directly to the skin. This simple, low-cost dia ...
DEC 23, 2020
Clinical & Molecular DX
Smartphone Device Uses CRISPR to Check for COVID
DEC 23, 2020
Smartphone Device Uses CRISPR to Check for COVID
Quick, portable, and ultrasensitive—a new smartphone test for COVID-19 checks all the boxes needed to get a handle ...
DEC 31, 2020
Clinical & Molecular DX
Silent Mice Drive Autism Gene Discovery
DEC 31, 2020
Silent Mice Drive Autism Gene Discovery
Around 1 in 54 children in the U.S. are diagnosed with autism spectrum disorder, or ASD, a broad range of conditions tha ...
JAN 08, 2021
Neuroscience
Can We Identify Alzheimer's from Routine Eye Exams?
JAN 08, 2021
Can We Identify Alzheimer's from Routine Eye Exams?
As people with diabetes age, they are more likely than those without the condition to develop cognitive disorders such a ...
FEB 23, 2021
Clinical & Molecular DX
Dogs Versus AI-Powered Diagnostic Devices-Who Won?
FEB 23, 2021
Dogs Versus AI-Powered Diagnostic Devices-Who Won?
We’ve heard of dogs sniffing out cancer—an unsurprising skill given that they have over 200 million scent re ...
Loading Comments...